TQC2731 injection for pulmonary disease, chronic obstructive

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Nov 2024: Trial registered, NCT06707883
  2. 31 Dec 2024: Trial started, NCT06707883

The trials

NCT06707883: A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

State
Under way
Phase
Phase 2
People
258 taking part
Started
31 Dec 2024
Primary completion
Dec 2026
Arms
TQC2731 injection
Results
None posted
  1. 27 Nov 2024: Trial registered
  2. 31 Dec 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.